Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells
about
Is lipid signaling through cannabinoid 2 receptors part of a protective system?Is the cardiovascular system a therapeutic target for cannabidiol?Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic reviewInteraction between Cannabinoid System and Toll-Like Receptors Controls InflammationMinocycline Attenuates Neonatal Germinal-Matrix-Hemorrhage-Induced Neuroinflammation and Brain Edema by Activating Cannabinoid Receptor 2The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cellsCB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in MiceProtective effects of cannabidiol on lesion-induced intervertebral disc degenerationRegulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation.Effects of cannabis on the adolescent brain.Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.The non-psychoactive plant cannabinoid, cannabidiol affects cholesterol metabolism-related genes in microglial cells.Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders.Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cellsCannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.Alkylindole-sensitive receptors modulate microglial cell migration and proliferation.Lonicera japonica THUNB. Extract Inhibits Lipopolysaccharide-Stimulated Inflammatory Responses by Suppressing NF-κB Signaling in BV-2 Microglial CellsPreclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist.Flax Fiber Hydrophobic Extract Inhibits Human Skin Cells Inflammation and Causes Remodeling of Extracellular Matrix and Wound Closure ActivationThe synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α.Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell deathThe multiplicity of action of cannabinoids: implications for treating neurodegeneration.Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive CannabinoidNeuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation.Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophagesCannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury.Cannabinoids decrease the th17 inflammatory autoimmune phenotype.Compartmentalization of endocannabinoids into lipid rafts in a microglial cell line devoid of caveolin-1.Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium.Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study.Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration.Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
P2860
Q24633122-2FFD34A2-F85C-414D-9F9C-DAC24BD15038Q26865370-EF3A5B9D-368F-4A05-843A-55C927186E04Q27005619-80113642-82A0-4D03-9B57-956283FD36C4Q28066215-288E656F-6F6D-4672-9CA9-2D914F459E16Q28109502-FF914D49-9103-4717-8BAE-08A1F6A608FDQ28236199-27040A4A-84C1-46DB-820B-F33AD7F12337Q28315817-1B665470-6812-4E3E-B20C-A20154B17ACAQ28542740-6A2E1C32-FFF0-499F-9386-AEA77BECFFEEQ30470076-8CA953A2-D6AB-4280-AD7E-3CE1B5836661Q30653619-F0E880D8-91DA-477D-BE84-CC00074965BBQ34117612-405CAFB9-3082-4145-A2BE-A0226D9D580CQ34181605-9D0D2E6C-F757-4A38-BBDD-7B696C5DDFD4Q34471868-BA34AB5A-A80F-4257-9F5A-C2A9BDB58D16Q34519365-8485BC0E-5DD8-4434-9D1E-9B5860909D47Q34557613-48E326AC-4A74-4DA4-9B4F-8A0744159C3DQ34700334-0299BD5D-64ED-4542-AAF1-44E54462DD7FQ34851941-3C07ADAA-C6D0-40A2-BA39-C7EF36DC3EE8Q34898890-A4FA85CE-E8B2-4AD2-9CC7-CC09E4F99AF4Q35186239-06AF87F9-ADA8-4E2D-989D-AE91735CAD2EQ35193309-F7D31513-C642-40CD-8AC0-7F4594B3041DQ35564928-7740ADCB-FCBD-4B4F-860F-A20EC0EC2186Q35822089-1605A70D-361F-4536-A3C8-F1AC158731F6Q35863912-9AC69F3D-0851-4DBC-A004-AB19ACFFB8EFQ35963966-28083A92-BB65-4046-8ACA-DCDE51C3B9B9Q36127141-F1FF8D2B-E28D-43F3-A658-2BFD52134C08Q36176444-2DDDF277-77EC-4670-A00E-3BFB1C3D8E11Q37424055-A83B79D2-B21D-4409-8A36-C65D3DC6FD16Q37793366-F82624FA-5AC1-4AC4-8684-C5337A72F1B5Q38324480-320A0DA6-AAE6-4F76-B0C1-CBD3416D1932Q38634379-50224DFE-3E6A-467D-A3DF-CD110CA114E0Q38684679-D8695A8B-D952-4281-8B6A-B50AA112F874Q38925905-2DD69C12-55A2-4F51-A66C-188794673299Q39000393-5AAC514C-3072-4B80-A812-21EFE00AE044Q39106041-7E1943C5-521B-4AC1-B84A-F8632AA1A895Q39119286-A4ED4440-9F2B-486B-AC2B-15573C880663Q39568285-C603B31C-BDD2-4A91-9CA3-09C57B6085ABQ41820315-8C1401CF-25CA-46CA-9913-094F43A8F60BQ41906876-458FEBAE-D128-4CE0-849B-36ADD8B3CAD8Q42314593-07E204CD-37D0-49F4-BB91-59BC9D800E75Q46293996-C1BF65A1-659E-4AC0-87C1-D80A136A66D3
P2860
Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cannabinoids Delta
@nl
Cannabinoids Delta(9)-tetrahyd ...... hways in BV-2 microglial cells
@ast
Cannabinoids Delta(9)-tetrahyd ...... hways in BV-2 microglial cells
@en
type
label
Cannabinoids Delta
@nl
Cannabinoids Delta(9)-tetrahyd ...... hways in BV-2 microglial cells
@ast
Cannabinoids Delta(9)-tetrahyd ...... hways in BV-2 microglial cells
@en
prefLabel
Cannabinoids Delta
@nl
Cannabinoids Delta(9)-tetrahyd ...... hways in BV-2 microglial cells
@ast
Cannabinoids Delta(9)-tetrahyd ...... hways in BV-2 microglial cells
@en
P2093
P2860
P921
P356
P1476
Cannabinoids Delta(9)-tetrahyd ...... hways in BV-2 microglial cells
@en
P2093
Ana Juknat
Ewa Kozela
Maciej Pietr
Neta Rimmerman
Rivka Levy
P2860
P304
P356
10.1074/JBC.M109.069294
P407
P577
2009-11-12T00:00:00Z